Glycerophospholipid biosynthetic process

pathway activity — cross-omics
GO:0046474Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Glycerophospholipid biosynthetic process pathway is significantly associated with the protein abundance of multiple proteins, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are RPL21, RPL5, and SERBP1, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Glycerophospholipid biosynthetic process activity versus RPL21 in LUAD (Pearson r = -0.26).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADRPL21 →-0.231-0.026.003<.00138
CCRCCRPL5 →-0.247-0.034<.001<.00138
GBMSERBP1 →-0.245-0.037<.001<.00138
GBMRPL4 →-0.293-0.026.003.00137
CCRCCRPS2 →-0.194-0.023.006<.00137
GBMSEPTIN4 →+0.527+0.022<.001<.00137
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0046474 vs RPL21 — LUAD

Per-sample scatter of Glycerophospholipid biosynthetic process activity vs RPL21 in LUAD.

Explore this scatter interactively →

Exploration